| Log in

Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

04 September, 2017

Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20 years ago to start his entrepreneurial journey. The Ahmedabad-based biotechnology company that he lat ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Rakesh Jhunjhunwala-backed Concord Biotech looking to enter biosimilars market

Rakesh Jhunjhunwala-backed Concord Biotech looking to enter biosimilars market

Lohit Jagwani 3 years ago
Ahmedabad-based bulk drug maker Concord Biotech Ltd is in talks with strategic...
Exclusive: Quadria invests in Rakesh Jhunjhunwala-backed Concord Biotech

Exclusive: Quadria invests in Rakesh Jhunjhunwala-backed Concord Biotech

Joseph Rai 2 years ago
India and Southeast Asia-focused healthcare private equity firm Quadria Capital...
FDA raises more concerns about Ranbaxy's India plants

FDA raises more concerns about Ranbaxy’s India plants

Reuters 4 years ago
The US Food and Drug Administration (FDA) has raised concerns about the...
No Comments

Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Powered by WordPress.com VIP